Did you become more reactive after COVID—or find that symptoms you already had became harder to live with?
In this episode, research scientist Brandy Searcy explores the connection between COVID and mast cell activation: how SARS-CoV-2 and its spike protein activate mast cells in experimental studies, what researchers have found lingering in the body months after infection, and why persistent viral material deserves attention as a potential driver of ongoing symptoms.
You’ll hear about findings from human intestinal biopsies, studies detecting circulating viral proteins, and experiments tracing how spike triggers the release of inflammatory mediators. Together, this research gives us a reason to ask: What is continuing to stimulate your immune response after the initial infection has passed?
Explore the physiology beneath your symptoms in my free 7-day course, The Physiology Driving POTS and MCAS. Choose the track that fits what you’re experiencing:
MCAS and histamine intolerance:
https://theflowtoheal.com/mcas-and-histamine-intolerance
POTS and dysautonomia:
https://theflowtoheal.com/pots-and-dysautonomia
References
Zollner A, et al. (2022). Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology.
https://doi.org/10.1053/j.gastro.2022.04.037
Swank Z, et al. (2023; published online 2022). Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical Infectious Diseases.
https://doi.org/10.1093/cid/ciac722
Peluso MJ, et al. (2024). Plasma-based antigen persistence in the post-acute phase of COVID-19. The Lancet Infectious Diseases.
https://doi.org/10.1016/S1473-3099(24)00211-1
Tan JYJ, et al. (2023). Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19. Journal of Clinical Investigation.
https://doi.org/10.1172/JCI149834
Wong AC, et al. (2023). Serotonin reduction in post-acute sequelae of viral infection. Cell.
https://doi.org/10.1016/j.cell.2023.09.013
Brogna C, et al. (2021). Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients. F1000Research. Version 2.
https://doi.org/10.12688/f1000research.54306.2
Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration. (2024). Journal of Inflammation Research.
https://doi.org/10.2147/JIR.S456000
Wu ML, et al. (2021). SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduction and Targeted Therapy.
https://doi.org/10.1038/s41392-021-00849-0
Tsilioni I, Theoharides TC. (2023). Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33. International Journal of Molecular Sciences.
https://doi.org/10.3390/ijms24119487
Zhang S, et al. (2025). Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca2+ intracellular signaling cascade. Journal of Virology.
https://doi.org/10.1128/jvi.00078-25
Augustin M, et al. (2026). Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control study. Mucosal Immunology.
https://doi.org/10.1016/j.mucimm.2026.03.002
University of Pennsylvania coverage mentioned in this episode
Penn Today. (October 17, 2023). Viral persistence and serotonin reduction can cause long COVID symptoms.
https://penntoday.upenn.edu/news/penn-medicine-viral-persistence-and-serotonin-reduction-can-cause-long-covid-symptoms